Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is DHG Pharmaceutical JSC ?
1
High Management Efficiency with a high ROE of 20.35%
2
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 57.01
3
Poor long term growth as Net Sales has grown by an annual rate of 5.44% over the last 5 years
4
Flat results in Jun 25
- INTEREST(HY) At VND 12,751.44 MM has Grown at 41.71%
5
With ROE of 22.34%, it has a fair valuation with a 3.50 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -5.56%, its profits have risen by 2.8% ; the PEG ratio of the company is 5.6
- At the current price, the company has a high dividend yield of 9.9
6
Below par performance in long term as well as near term
- Along with generating -5.56% returns in the last 1 year, the stock has also underperformed Vietnam VN Ho Chi Minh Index in the last 3 years, 1 year and 3 months
How much should you hold?
- Overall Portfolio exposure to DHG Pharmaceutical JSC should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is DHG Pharmaceutical JSC for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
DHG Pharmaceutical JSC
-5.12%
-0.97
17.54%
Vietnam VN Ho Chi Minh Index
29.95%
1.61
21.07%
Quality key factors
Factor
Value
Sales Growth (5y)
5.44%
EBIT Growth (5y)
5.69%
EBIT to Interest (avg)
57.01
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.47
Sales to Capital Employed (avg)
0.98
Tax Ratio
13.16%
Dividend Payout Ratio
173.53%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
45.64%
ROE (avg)
20.35%
Valuation Key Factors 
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
3.50
EV to EBIT
12.00
EV to EBITDA
10.44
EV to Capital Employed
5.38
EV to Sales
2.37
PEG Ratio
5.59
Dividend Yield
9.86%
ROCE (Latest)
44.85%
ROE (Latest)
22.34%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
Mildly Bearish
Technical Movement
5What is working for the Company
OPERATING CASH FLOW(Y)
Highest at VND 1,566,796.65 MM
RAW MATERIAL COST(Y)
Fallen by -10.05% (YoY
INVENTORY TURNOVER RATIO(HY)
Highest at 2.16%
-4What is not working for the Company
INTEREST(HY)
At VND 12,751.44 MM has Grown at 41.71%
Here's what is working for DHG Pharmaceutical JSC
Operating Cash Flow
Highest at VND 1,566,796.65 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (VND MM)
Inventory Turnover Ratio
Highest at 2.16%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -10.05% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for DHG Pharmaceutical JSC
Interest
At VND 12,751.44 MM has Grown at 41.71%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (VND MM)






